Zoetis Inc. $ZTS Shares Acquired by BNP PARIBAS ASSET MANAGEMENT Holding S.A.

BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its holdings in Zoetis Inc. (NYSE:ZTS) by 28.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 578,621 shares of the company’s stock after buying an additional 126,567 shares during the quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. owned about 0.13% of Zoetis worth $84,310,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in ZTS. Halbert Hargrove Global Advisors LLC grew its stake in shares of Zoetis by 496.6% in the third quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock worth $25,000 after purchasing an additional 144 shares in the last quarter. NewSquare Capital LLC grew its position in Zoetis by 69.1% in the 2nd quarter. NewSquare Capital LLC now owns 208 shares of the company’s stock valued at $32,000 after buying an additional 85 shares in the last quarter. Financial Consulate Inc. acquired a new position in Zoetis during the 3rd quarter valued at about $39,000. SJS Investment Consulting Inc. raised its position in shares of Zoetis by 1,606.3% during the 3rd quarter. SJS Investment Consulting Inc. now owns 273 shares of the company’s stock worth $40,000 after buying an additional 257 shares in the last quarter. Finally, TruNorth Capital Management LLC acquired a new stake in shares of Zoetis in the 3rd quarter worth approximately $42,000. Institutional investors own 92.80% of the company’s stock.

Analyst Ratings Changes

ZTS has been the topic of a number of research analyst reports. JPMorgan Chase & Co. lowered their price objective on shares of Zoetis from $230.00 to $200.00 and set an “overweight” rating on the stock in a research note on Wednesday, November 5th. Piper Sandler reiterated a “neutral” rating and set a $135.00 price target (down from $190.00) on shares of Zoetis in a research report on Thursday, January 22nd. Morgan Stanley set a $160.00 price objective on Zoetis in a research note on Thursday, December 18th. KeyCorp began coverage on Zoetis in a research note on Thursday, November 20th. They set a “sector weight” rating for the company. Finally, Barclays initiated coverage on Zoetis in a report on Monday, December 8th. They set an “equal weight” rating and a $136.00 target price on the stock. Five research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $152.91.

Zoetis Trading Down 1.6%

Shares of NYSE ZTS opened at $127.12 on Friday. The company has a quick ratio of 1.94, a current ratio of 3.03 and a debt-to-equity ratio of 2.71. Zoetis Inc. has a 12 month low of $115.25 and a 12 month high of $177.00. The company has a market cap of $53.66 billion, a price-to-earnings ratio of 21.12, a P/E/G ratio of 1.97 and a beta of 0.96. The business has a fifty day simple moving average of $125.20 and a 200-day simple moving average of $134.96.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Thursday, February 12th. The company reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.08. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The firm had revenue of $2.39 billion for the quarter, compared to the consensus estimate of $2.36 billion. During the same quarter in the previous year, the company earned $1.40 EPS. The business’s revenue for the quarter was up 3.0% compared to the same quarter last year. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Sell-side analysts predict that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 2nd. Investors of record on Monday, April 20th will be paid a $0.53 dividend. The ex-dividend date of this dividend is Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a yield of 1.7%. Zoetis’s dividend payout ratio (DPR) is currently 35.22%.

Zoetis Company Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.